LRMN and Thermo Fisher Scientific meeting agenda
The November 2014 meeting of the LRMN, sponsored by Thermo Fisher Scientific, will focus on the scalable manufacturing of cell therapies.
The November 2014 meeting of the LRMN will focus on the scalable manufacturing of cell therapies. Each of the three speakers has unique insight into the challenges and potential solutions to deliver cell therapies at the scale required for routine clinical practice.
This free-to-attend meeting is kindly supported by Thermo Fisher Scientific and will take place on Wednesday 12th November 2014 at 6.00pm in the Medical Sciences 131 A V Hill Lecture Theatre, Medical Sciences and Anatomy Building, University College London.
Agenda
18.00 – Registration and networking over tea and coffee in the Medical Sciences 131 A V Hill Lecture Theatre (Medical Sciences and Anatomy Building, UCL), while previewing the LRMN Cell Therapy Masterclass with Dr. Kim Warren, Head of Custom Development Services for Cell Therapy at Lonza Walkersville Inc. (Walkersville, MD, USA)
18.30 – Welcome – Myriam Jordan (Thermo Fisher Scientific) and Dr. Emily Culme-Seymour (LRMN)
18.35 – The industrialisation of stem cell production – Aidan Courtney, Roslin Cells Ltd. (Edinburgh, UK)
19.05 – Q & A
19.10 – Maturing adherent-cell therapies for commercialisation: Strategies, technology barriers and possible solutions – Dr. Ohad Karnieli, Pluristem Therapeutics Inc. (Haifa, Israel)
19.40 – Q & A
19.45 – Addressing healthcare challenges posed by an aging global population, through innovative regenerative medicine technologies and advances in regulatory strategies – Dr. Gil Van Bokkelen, Athersys Inc. (Cleveland, OH, USA)
20.15 – Q & A
20.20 – Closing remarks – Myriam Jordan (Thermo Fisher Scientific) and Dr. Emily Culme-Seymour (LRMN)
20.25 – 22.00 – LRMN Reception – Network whilst enjoying a glass of wine or two in the Garden Room (Wilkins Building, UCL)
Attendance
I and my lovely colleague Elena, the Regenerative Medicine Commissioning Editor, will be attending this essential meeting, if anyone fancies a chat! The last LRMN event was fantastic — genuinely engaging presentations on essential topics — so we are really looking forward to this next event.
Are you attending this meeting? What are your thoughts on achieving scalable, cost-effective manufacturing strategies for cell therapies? Let us know in the comments below!